The Rise of Regen BioPharma - The Future of Medicine
Great post!
Like I've said MANY times before, one thing for CERTAIN the Naked Short Selling MMs can't handle massive surges in BUY Volume!
Predictively that's what is going to happen Post-Pink Current.
It might not happen the same day or even the same week BUT it's going to happen as masses of investors worldwide are getting wind of being able to buy this stock on any brokerage platform. This is in ALL Countries World-Wide, and this combined with the emergence of an all new OTC that's smaller in size due to the elimination of non-SEC Compliant stocks, very few remaining have anywhere near the Market Capacity of RGBP that in reality IMO is a NASDAQ caliber stock that could of opened on NASDAQ as an IPO based alone on its 20+ Patent portfolio each having a Billion Dollar Market potential with their mRNA based Patents.
Keep in mind that Kite Pharma was bought out by Gilead Sciences in 2017 for $11.9 Billion Cash in order to acquire their only Patent in the mRNA Immuno-Oncology space. At that time their Patent was not FDA approved Patent for an IND. RGBP is in the exact same space but with FDA approval for (2) INDs for treating pancreatic and colon cancer that has a very high probability of going to Market.
My estimate time frame for the surge in massive buy volume beginning to set in may take at 10-to-15 trading days Post-Pink Current. OR it could begin happening the very next day! For ENZ*C it took 19 trading days Post-Pink Current for the massive buy volume to set in day after day that sent the PPS to nearly $1.00.
Either way, IMO $1.00 to 2.00 Post Pink current short term, possibly higher based on our current Market Profile with (1) Active FDA Approved mRNA Patent with (2) Licensed INDs for treating pancreatic & colon cancer already in progress entering into formal clinical trials any day, PLUS it has a very high probability of making it to Market for Global Commercialization, at least 95%.
This is absolutely so huge that most people probably don't realize it keeping in mind that pancreatic cancer is presently the 3rd leading cause of ALL cancer related deaths, and this Patent, so far, is the only hope for changing that.
Imagine for a moment an mRNA Vaccine based on RGBP's NR2F6 Patent having an "immunization effect" on cancer cells. That's what this is! Other words the ability to "deactivate" or "switch off" cancer cell's life cycle thereby stopping the growth & spread of cancer in its tracks.
The implications of this science is absolutely astonishing BUT with RGBP NR2F6 Patent currently in play via Oncology Pharma taking it to clinical trials, it is well on its way of not only becoming a reality, but also having the potential to PREVENT people from getting cancer in the first place!
Imagine a day will come when people can get an mRNA Vaccine (like a flu shot) that will provide systemic immunity against various forms of Cancer! That's exactly the direction all of this is going in...like I've said hundreds of times "it is the Future of Medicine"
RGBP's Disruptive Biotechnology Patent currently in play will be foundational to ushering Humanity into "THE NEW AGE OF MEDICINE" where cancer will no longer be a death sentence, but instead a manageable disease no longer associated with extreme suffering and death, and at some point the possible elimination of deadly cancers altogether.
The Big Pharma that this kind of biotechnology is consistent with is CRISPR known for their "gene editing" science that's has the potential of eliminating various diseases. It's presently trading in the $128-$130 range and it wouldn't surprise me at all if RGBP is acquired by that company but that's anyone's guess.
Personal opinion only but one that makes common sense.
Be well and prosper...
